Biotechnology fuels growth of new meds and vaccines

Share this article:

Three hundred and twenty-four new medicines and vaccines developed through biotechnology are now being tested to treat nearly 150 diseases, according to a new survey of biotechnology medicines released by the Pharmaceutical Research
and Manufacturers of America (PhRMA). All of the new biotechnology
medicines and vaccines are now in clinical trails or awaiting approval from the FDA. The survey found that the new biotechnology medicines include 154 medicines to treat cancer, 43 to treat
infectious disease, 26 to treat autoimmune disorders, 16 to treat neurological disorders and 17 to treat HIV/AIDS and related-conditions.
"The biotechnology medicine revolution is giving patients and doctors
new hope and new tools to fight disease," said Alan Holmer, PhRMA
president and chief executive.

Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.